Hudson Bay Capital Management LP's Net Worth

$102 Million

Estimate Recalculated Apr 25, 2024 04:12PM EST

Who is Hudson Bay Capital Management LP?

Hudson Bay Capital Management LP has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Moringa Acquisition Corp, EnteroMedics Inc, CHEM RX CORP, M I Acquisitions, Inc., Stellar Acquisition III Inc., SCVX Corp., INNOVATE Corp., Longevity Acquisition Corp, Benessere Capital Acquisition Corp., Akers Biosciences, Inc., GALENA BIOPHARMA, INC., Alberton Acquisition Corp, Yunhong International, Trident Acquisitions Corp., East Stone Acquisition Corp, Jensyn Acquisition Corp., AMCI Acquisition Corp., Tenzing Acquisition Corp., 24HOLDINGS INC, Twin Ridge Capital Acquisition Corp., Greencity Acquisition Corp, Mountain Crest Acquisition Corp. IV, Alset Capital Acquisition Corp., First Light Acquisition Group, Inc., and Model Performance Acquisition Corp.

SEC CIK

Hudson Bay Capital Management LP's CIK is 0001393825

Past Insider Trading and Trends

2019 was Hudson Bay Capital Management LP's most active year for acquiring shares with 12 total transactions. Hudson Bay Capital Management LP's most active month to acquire stocks was the month of November. 2020 was Hudson Bay Capital Management LP's most active year for disposing of shares, totalling 13 transactions. Hudson Bay Capital Management LP's most active month to dispose stocks was the month of June. 2020 saw Hudson Bay Capital Management LP paying a total of $7,778,149.16 for 3,112,306 shares, this is the most they've acquired in one year. In 2020 Hudson Bay Capital Management LP cashed out on 3,593,181 shares for a total of $34,266,146.06, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 14
Form 3
—
0
—
—
0
No matching records found

Moringa Acquisition Corp (MACA) Snapshot price: $11.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-401.27K
$10.60
-$4,253,472.60
0
Aug 22
Form 3
—
0
—
—
0
No matching records found

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
Form 4
-24.10%
-2.43M
$0.97
-$2,448,482.46
7.66M
Oct 2 - Oct 5
No matching records found

CHEM RX CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-66.10%
-1.44M
$5.99
-$8,608,055.11
737K
Jul 22 - Jul 23
Form 4
-0.10%
-3.00K
$6.43
-$19,250.00
2.88M
Dec 3
Form 3
—
0
—
—
0
No matching records found

M I Acquisitions, Inc. (PRTH) Snapshot price: $3.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.52%
-197.71K
$10.60
-$2,095,694.20
1.26M
Jul 9 - Jul 12
Form 3
—
0
—
—
0
No matching records found